Search

Your search keyword '"Cobo-Marcos, M."' showing total 90 results

Search Constraints

Start Over You searched for: Author "Cobo-Marcos, M." Remove constraint Author: "Cobo-Marcos, M."
90 results on '"Cobo-Marcos, M."'

Search Results

3. Design and baseline characteristics of SALT‐HF trial: hypertonic saline therapy in ambulatory heart failure.

4. Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry

5. Differences between familial and sporadic dilated cardiomyopathy: ESC EORP Cardiomyopathy & Myocarditis registry

6. Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registry

7. Sex‐ and age‐related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long‐Term Registry

8. Serum potassium dynamics during acute heart failure hospitalization

9. Utility of plasma CA125 as a proxy of intra-abdominal pressure in patients with acute heart failure

10. Hypertensive disorders in women with peripartum cardiomyopathy: insights from the ESC EORP PPCM Registry

11. Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry

12. Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry

13. Infective endocarditis after transcatheter aortic valve implantation

14. Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry

15. Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world

16. Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry

17. Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry

18. Unravelling the interplay between hyperkalaemia, renin–angiotensin–aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry

19. Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry

20. Dilated Cardiomyopathy Due to BLC2-Associated Athanogene 3 (BAG3) Mutations

21. Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry

24. 392 Genetic Basis of Heart Transplanted Hypertrophic Cardiomyopathy

25. 564 Desmosomal Protein Gene Mutations in Patients with Idiopathic Dilated Cardiomyopathy Undergoing Cardiac Transplantation: A Clinicopathological Study

26. Thromboembolic events in peripartum cardiomyopathy: results from the ESC EORP PPCM registry

27. Clinical characteristics of wild-type transthyretin cardiac amyloidosis – Disproving myths

28. Incidence and predictors of sudden death in patients with cardiac amyloidosis.

29. Efficacy and safety of hypertonic saline therapy in ambulatory patients with heart failure: The SALT-HF trial.

30. Heart Failure Knowledge Assessment and Perceived Patient Satisfaction in Heart Failure Units: A Multicenter Observational Survey.

31. Impact of natriuresis on worsening renal function during episodes of acute heart failure.

32. Combinational Diuretics in Heart Failure.

33. Influence of the medical treatment schedule in new diagnoses patients with heart failure and reduced ejection fraction.

34. Congestion as a crucial factor determining albuminuria in patients with cardiorenal disease.

35. Clinical impact of remote heart failure management using the multiparameter ICD HeartLogic alert.

36. Usefulness of Antigen Carbohydrate 125 and N-Terminal Pro-B-Type Natriuretic Peptide for Assessing Congestion in Chronic Heart Failure: Insights from the CARDIOREN Registry.

37. Practical Approaches to the Management of Cardiorenal Disease beyond Congestion.

38. Protocolized Natriuresis-Guided Decongestion Improves Diuretic Response: The Multicenter ENACT-HF Study.

39. Prevalence and clinical profile of kidney disease in patients with chronic heart failure. Insights from the Spanish cardiorenal registry.

40. Diagnosis of heart failure with preserved ejection fraction: a systematic narrative review of the evidence.

41. Predictors and outcomes of pacemaker implantation in patients with cardiac amyloidosis.

42. Case report: Alternative approach for management of refractory volume overload in heart failure: usefulness of venous leg compression.

43. Impact of dapagliflozin on cardiac remodelling in patients with chronic heart failure: The DAPA-MODA study.

44. Sex differences in Cardiorenal Syndrome: Insights from CARDIOREN Registry.

46. Do Women Physicians Accept and Follow Heart Failure Guidelines More Than Men?

47. Intermittent inotropic support with levosimendan in advanced heart failure as destination therapy: The LEVO-D registry.

48. Usefulness of Systemic Venous Ultrasound Protocols in the Prognosis of Heart Failure Patients: Results from a Prospective Multicentric Study.

49. Frequency of hereditary transthyretin amyloidosis among elderly patients with transthyretin cardiomyopathy.

50. Endomyocardial biopsy-confirmed myocarditis and inflammatory cardiomyopathy: clinical profile and prognosis.

Catalog

Books, media, physical & digital resources